Edmund Nesti
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2025First federal award
$3.0MFederal grants as PI2 awards
1Patents grantedLatest Dec 31, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 4, 2026 | NIH | SBIR Phase II FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain | $1.5M | ALCAMENA STEM CELL THERAPEUTICS, LLC |
| Aug 7, 2025 | NIH | SBIR Phase II FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain | $1.5M | ALCAMENA STEM CELL THERAPEUTICS, LLC |
2 patents as inventor
- US 12180255ALCAMENA STEM CELL THERAPEUTICS, LLCDec 31, 2024
- US ALCAMENA STEM CELL THERAPEUTICS, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#602
Awards as PI#1,252
Patents#155
Companies
- ALCAMENA STEM CELL THERAPEUTICS, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.